The present invention provides a novel antibody binding to human GPRC5D and a molecule which contains the antibody and is capable of binding to an antigen. Provided are: a novel antibody binding to human GPRC5D; a molecule which contains the antibody and is capable of binding to an antigen; an antitumor medicinal composition which contains the antibody or the molecule as an active ingredient, etc.